File Download

There are no files associated with this item.

Supplementary

Conference Paper: Combined use of Ivabradine and Olaparib as a novel therapeutic strategy for triple-negative breast cancer

TitleCombined use of Ivabradine and Olaparib as a novel therapeutic strategy for triple-negative breast cancer
Authors
Leung, MHTsoi, HMan, PSGong, CKhoo, US
Issue Date2021
Citation
The Virtual New Zealand Breast Cancer Symposium, 2021 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/323553

 

DC FieldValueLanguage
dc.contributor.authorLeung, MH-
dc.contributor.authorTsoi, H-
dc.contributor.authorMan, PS-
dc.contributor.authorGong, C-
dc.contributor.authorKhoo, US-
dc.date.accessioned2023-01-08T07:08:02Z-
dc.date.available2023-01-08T07:08:02Z-
dc.date.issued2021-
dc.identifier.citationThe Virtual New Zealand Breast Cancer Symposium, 2021-
dc.identifier.urihttp://hdl.handle.net/10722/323553-
dc.languageeng-
dc.relation.ispartofThe Virtual New Zealand Breast Cancer Symposium, 2021-
dc.titleCombined use of Ivabradine and Olaparib as a novel therapeutic strategy for triple-negative breast cancer-
dc.typeConference_Paper-
dc.identifier.emailLeung, MH: mhl2018@HKUCC-COM.hku.hk-
dc.identifier.emailTsoi, H: tsoiho@hku.hk-
dc.identifier.emailMan, PS: ellenman@hku.hk-
dc.identifier.emailKhoo, US: uskhoo@hku.hk-
dc.identifier.authorityKhoo, US=rp00362-
dc.identifier.hkuros343290-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats